Eligibility Pre-Screening

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 70%

1.Have you been diagnosed with cutaneous melanoma (a type of skin cancer)?

Press Y/N or 1/2